Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMED.L Regulatory News (MED)

  • There is currently no data for MED

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8.3- MicroEmissive Displ

18 Aug 2008 16:54

RNS Number : 5685B
Robert Jeens
18 August 2008
 



FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

(Rule 8.3 of the City Code on Takeovers and Mergers)

 

1. KEY INFORMATION

Name of person dealing (Note 1)

Robert Jeens

Company dealt in

MicroEmissive Displays plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

Ords

Date of dealing

15 August 2008

 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

 

(a)

Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

 

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities 

600,000

1.01

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

 

(b)

Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 Class of relevant security:

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

 

(c) Rights to subscribe (Note 3)

 

Class of relevant security:

Details

3. DEALINGS (Note 4)

 

(a) Purchases and sales

 

Purchase/sale 

Number of securities

Price per unit (Note 5)

Purchase

150,000

3.99p

 

(b) Derivatives transactions (other than options)

 

Product name,

e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

 

Product

name, e.g.

call option 

Writing,

selling,

purchasing,

varying etc.

Number of

securities to

which the

option

relates

(Note 7)

Exercise

price 

Type, e.g.

American,

European

etc.

Expiry

date

Option

money

paid/received

per unit (Note

5) 

 

 

(ii) Exercising

 

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 5)

 

(d) Other dealings (including new securities) (Note 4)

 

Nature of transaction (Note 8) 

Details

Price per unit (if applicable) (Note 5)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)

YES/NO

 

Date of disclosure

18 August 2008

Contact name

Robert Jeens

Telephone number

020 8946 9304

If a connected EFM, name of offeree/offeror with which connected

If a connected EFM, state nature of connection (Note 10)

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETGUUQCRUPRGAR
Date   Source Headline
23rd May 20177:00 amRNSAGM Statement
26th Apr 20177:00 amRNSNotice of AGM
4th Apr 20172:53 pmRNSGrant of options
22nd Mar 20178:35 amRNSFinal Results
26th Jan 201711:30 amRNSPatent Infringement Settlement & Trading update
16th Dec 20167:24 amRNSPatent Infringement Settlement
27th Oct 20167:00 amRNSNew Ultrasound Simulation Suite with ScanTrainer
22nd Sep 20167:00 amRNSDirector appointment
15th Sep 20167:00 amRNSScanTrainer Professional approved for CPD points
12th Sep 20167:00 amRNSBSE approves HeartWorkd eLearn for TOE syllabus
8th Sep 20167:01 amRNSLaunch of new ScanExaminer simulator
8th Sep 20167:00 amRNSNotice of material contract change
12th Aug 20162:40 pmRNSHolding(s) in Company
3rd Aug 20167:01 amRNSAcquisition
3rd Aug 20167:00 amRNSHalf-year Report
5th Jul 20167:00 amRNSMedaphor North America expands US sales team
29th Jun 20167:00 amRNSUpdates to ScanTrainer Professional 2016 version
11th May 201611:20 amRNSResult of AGM
11th May 20167:00 amRNSAGM Statement
27th Apr 20167:00 amRNSNotice of Patent Infringement Proceedings
20th Apr 201610:49 amRNSHolding(s) in Company
19th Apr 201612:05 pmRNSResult of General Meeting
8th Apr 201611:28 amRNSNotice of AGM
1st Apr 20167:00 amRNSFinal Results
1st Apr 20167:00 amRNSPlacing to raise £3.2 million
1st Mar 20167:00 amRNSMedaPhor signs agreement with ABOG
18th Jan 20167:00 amRNSLaunch of Cloud 2 service
8th Dec 20158:43 amRNSCorrection: Trading Update
8th Dec 20157:00 amRNSTrading Update
26th Nov 20157:00 amRNSMedaPhor signs reseller partner in France
11th Nov 20157:00 amRNSContract win with Teesside University
27th Oct 20157:00 amRNSMedaPhor expands into Spain and Portugal
1st Oct 20157:00 amRNSContract Win
8th Sep 20157:00 amRNSScanTrainer passes patient case milestone
30th Jul 20157:00 amRNSInterim Results
13th Jul 20157:00 amRNSEnhancement to ScanTrainer product portfolio
24th Jun 20157:00 amRNSCollaboration with Inventive Medical
6th May 201512:15 pmRNSResult of AGM
6th May 20157:01 amRNSAGM Statement
30th Apr 20157:00 amRNSScanTrainer released in French, German and Spanish
2nd Apr 20157:00 amRNSExpansion into South Africa
1st Apr 20157:00 amRNSNotice of AGM
12th Mar 20157:00 amRNSPreliminary Results
3rd Mar 20157:00 amRNSScanTrainer released in Chinese and Japanese
28th Jan 20157:00 amRNSInnovators & Investors Forum
26th Jan 201510:12 amRNSNew module launched to enhance product offering
8th Jan 20157:00 amRNSTrading Statement
19th Dec 20142:28 pmRNSIssue of Equity
11th Nov 20147:00 amRNSLaunch of software update and cloud connectivity
24th Sep 20147:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.